145 related articles for article (PubMed ID: 26491862)
1. Population Pharmacokinetics of Fentanyl in the Critically Ill.
Choi L; Ferrell BA; Vasilevskis EE; Pandharipande PP; Heltsley R; Ely EW; Stein CM; Girard TD
Crit Care Med; 2016 Jan; 44(1):64-72. PubMed ID: 26491862
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and transdermal fentanyl in alpacas.
Lovasz M; Aarnes TK; Hubbell JAE; Bednarski RM; Lerche P; Lakritz J
J Vet Pharmacol Ther; 2017 Dec; 40(6):663-669. PubMed ID: 28317124
[TBL] [Abstract][Full Text] [Related]
3. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Fentanyl Variability Using Population Pharmacokinetics in Pediatric Burn Patients.
Grimsrud KN; Lima KM; Tran NK; Palmieri TL
J Burn Care Res; 2020 Jan; 41(1):8-14. PubMed ID: 31538188
[TBL] [Abstract][Full Text] [Related]
5. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
Plock N; Facius A; Hartmann L; Baumann S; Nave R
Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
[TBL] [Abstract][Full Text] [Related]
6. Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.
Hagos FT; Horvat CM; Au AK; Conley YP; Li L; Poloyac SM; Kochanek PM; Clark RSB; Empey PE
Clin Pharmacokinet; 2019 Dec; 58(12):1567-1576. PubMed ID: 31168770
[TBL] [Abstract][Full Text] [Related]
7. Validation of fentanyl pharmacokinetics in patients undergoing coronary artery bypass grafting.
Hudson RJ; Thomson IR; Henderson BT; Singh K; Harding G; Peterson DJ
Can J Anaesth; 2002 Apr; 49(4):388-92. PubMed ID: 11927479
[TBL] [Abstract][Full Text] [Related]
8. The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation.
Jin SJ; Jung JY; Noh MH; Lee SH; Lee EK; Choi BM; Song MH; Noh GJ
Clin Pharmacol Ther; 2011 Sep; 90(3):423-31. PubMed ID: 21814196
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl Pharmacokinetics in Critically Ill Patients: A Demonstration of Mixed Effects.
Droege CA; Mueller EW
Crit Care Med; 2016 Jan; 44(1):240-2. PubMed ID: 26672932
[No Abstract] [Full Text] [Related]
10. Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns.
Kaneda K; Han TH
Burns; 2009 Sep; 35(6):790-7. PubMed ID: 19501972
[TBL] [Abstract][Full Text] [Related]
11. Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients.
Oosten AW; Abrantes JA; Jönsson S; de Bruijn P; Kuip EJ; Falcão A; van der Rijt CC; Mathijssen RH
Eur J Clin Pharmacol; 2016 Apr; 72(4):459-67. PubMed ID: 26762381
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients.
Miller RS; Peterson GM; Abbott F; Maddocks I; Parker D; McLean S
Br J Clin Pharmacol; 1995 Dec; 40(6):553-6. PubMed ID: 8703661
[TBL] [Abstract][Full Text] [Related]
13. Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management.
Bista SR; Haywood A; Hardy J; Norris R; Hennig S
J Clin Pharmacol; 2016 Jun; 56(6):705-13. PubMed ID: 26381285
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl clearance and volume of distribution are increased in patients with major burns.
Han T; Harmatz JS; Greenblatt DJ; Martyn JA
J Clin Pharmacol; 2007 Jun; 47(6):674-80. PubMed ID: 17428913
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of a constant rate infusion of fentanyl (5 μg/kg/h) in awake cats.
Ambros B; Alcorn J; Duke-Novakovski T; Livingston A; Dowling PM
Am J Vet Res; 2014 Aug; 75(8):716-21. PubMed ID: 25061702
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
Parikh N; Goskonda V; Chavan A; Dillaha L
Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
[TBL] [Abstract][Full Text] [Related]
17. Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants.
Saarenmaa E; Neuvonen PJ; Fellman V
J Pediatr; 2000 Jun; 136(6):767-70. PubMed ID: 10839874
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients.
Bartkowska-Śniatkowska A; Bienert A; Wiczling P; Rosada-Kurasińska J; Zielińska M; Warzybok J; Borsuk A; Tibboel D; Kaliszan R; Grześkowiak E
J Clin Pharmacol; 2016 Jan; 56(1):109-15. PubMed ID: 26105145
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
Carroll GL; Hooper RN; Boothe DM; Hartsfield SM; Randoll LA
Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.
Kaessner N; Nave R; Roepcke S; Facius A; Lahu G
Int J Clin Pharmacol Ther; 2012 Sep; 50(9):665-77. PubMed ID: 22784611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
